
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025
Long-Term Follow-Up Data from LEAP-002 Offers Insights into Hepatocellular Carcinoma Treatment Pipeline Data in Endometrial Carcinoma Among Studies to be Presented NUTLEY, N.J., May 20, 2025 /PRNewswire/ -- Eisai announced today the presentation of …